Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128


Successful gamma knife radiosurgery combined with S-1 in an elderly man with local recurrent pancreatic cancer: A case report.

Wei J, Dong X, Du F, Tang S, Wei H.

Medicine (Baltimore). 2017 Dec;96(51):e9338. doi: 10.1097/MD.0000000000009338.


Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor Size.

Kurata M, Honda G, Murakami Y, Uemura K, Satoi S, Motoi F, Sho M, Matsumoto I, Kawai M, Yanagimoto H, Fukumoto T, Nagai M, Gosho M, Unno M, Yamaue H; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).

World J Surg. 2017 Nov;41(11):2867-2875. doi: 10.1007/s00268-017-4077-5.


Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy.

Kipps E, Young K, Starling N.

Ther Adv Med Oncol. 2017 Mar;9(3):159-170. doi: 10.1177/1758834016688816. Epub 2017 Mar 1. Review.


The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.

Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu Y, Yao Y, Li D.

Mol Cancer. 2017 Feb 28;16(1):52. doi: 10.1186/s12943-017-0624-9. Review.


Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.

Chen M, Maeng K, Nawab A, Francois RA, Bray JK, Reinhard MK, Boye SL, Hauswirth WW, Kaye FJ, Aslanidi G, Srivastava A, Zajac-Kaye M.

Hum Gene Ther Methods. 2017 Feb;28(1):49-59. doi: 10.1089/hgtb.2016.089.


Short- and long-term outcomes after pancreaticoduodenectomy following total gastorectomy: Report of case series and literature review.

Yokoyama S, Ueno K, Higashide Y, Noma A, Okishio Y, Masuda M, Miyamoto T, Kamimura R, Hosokawa S, Yonenaga Y, Ito D, Ichimiya M, Yamashita Y, Uyama S, Harb SE.

Int J Surg Case Rep. 2017;30:118-121. doi: 10.1016/j.ijscr.2016.11.022. Epub 2016 Nov 27.


Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.

Kim HJ, Lee WJ, Kang CM, Hwang HK, Bang SM, Song SY, Seong J.

PLoS One. 2016 Jun 22;11(6):e0157196. doi: 10.1371/journal.pone.0157196. eCollection 2016.


Pancreatic Lesion: Malignancy or Abscess?

Shulik O, Cavanagh Y, Grossman M.

Am J Case Rep. 2016 May 18;17:337-9.


Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma.

Tai CJ, Huang MT, Wu CH, Wang CK, Tai CJ, Chang CC, Hsieh CI, Chang YJ, Wu CJ, Kuo LJ, Wei PL, Chen RJ, Chiou HY.

Medicine (Baltimore). 2016 Apr;95(15):e3259. doi: 10.1097/MD.0000000000003259.


B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer.

Xu H, Chen X, Tao M, Chen K, Chen C, Xu G, Li W, Yuan S, Mao Y.

Oncol Lett. 2016 Mar;11(3):1841-1846. Epub 2016 Jan 19.


Current Status of Biliary Metal Stents.

Nam HS, Kang DH.

Clin Endosc. 2016 Mar;49(2):124-30. doi: 10.5946/ce.2016.023. Epub 2016 Feb 25. Review.


Neoadjuvant treatment for resectable pancreatic adenocarcinoma.

Wong J, Solomon NL, Hsueh CT.

World J Clin Oncol. 2016 Feb 10;7(1):1-8. doi: 10.5306/wjco.v7.i1.1.


Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant.

Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, Knight J, El-Rayes B, Kooby D, Sarmiento J, Muraki T, Oliva I, Bandyopadhyay S, Akkas G, Goodman M, Reid MD, Krasinskas A, Everett R, Adsay V.

Ann Surg Oncol. 2016 Jun;23(6):2010-8. doi: 10.1245/s10434-016-5093-7. Epub 2016 Jan 29.


Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ.

J Surg Oncol. 2016 Feb;113(2):188-93. doi: 10.1002/jso.24125. Epub 2015 Dec 18.


An Update to Hepatobiliary Stents.

Moy BT, Birk JW.

J Clin Transl Hepatol. 2015 Mar;3(1):67-77. doi: 10.14218/JCTH.2015.00040. Epub 2015 Mar 15. Review.


Treatment of Pancreatic Cancer with Pharmacological Ascorbate.

Cieslak JA, Cullen JJ.

Curr Pharm Biotechnol. 2015;16(9):759-70. Review.


Pancreatic cancer, treatment options, and GI-4000.

Hartley ML, Bade NA, Prins PA, Ampie L, Marshall JL.

Hum Vaccin Immunother. 2015;11(4):931-7. doi: 10.1080/21645515.2015.1011017. Review.


Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.

Kaira K, Arakawa K, Shimizu K, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Takeyoshi I.

Am J Transl Res. 2015 Feb 15;7(2):356-63. eCollection 2015.


LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.

Hong CS, Ho W, Zhang C, Yang C, Elder JB, Zhuang Z.

Cancer Biol Ther. 2015;16(6):821-33. doi: 10.1080/15384047.2015.1040961. Epub 2015 Apr 21. Review.


Pancreatic cancer in an Asian population.

Kongkam P, Benjasupattananun P, Taytawat P, Navicharoen P, Sriuranpong V, Vajragupta L, Klaikaew N, Ridtitid W, Treeprasertsuk S, Rerknimitr R, Kullavanijaya P.

Endosc Ultrasound. 2015 Jan-Mar;4(1):56-62. doi: 10.4103/2303-9027.151361.

Supplemental Content

Support Center